Imaging and physical examinations are no longer necessary! Very Early Detection of Major Diseases is Now Possible with Blood Draws Alone!

We aim for a body that is “disease-free and never too late” with state-of-the-art medical technology.

We are pleased to announce that we have introduced the revolutionary Cancer Gene Test (VIP), which can detect major diseases with only a blood test. The microRNA cancer gene test (very early detection) enables disease prevention and very early detection of diseases.

This test does not examine the original genes, but rather examines the current condition of the patient through a blood test. It is recommended to have the test done regularly, once a year. It is also possible to detect pancreatic cancer, which is generally difficult to detect by diagnostic imaging.

What is Genetic and Cancer Genetic Testing VIP?

Inspection Contents

1. microRNA cancer gene test (very early detection), Alzheimer’s disease and stroke test

In cutting-edge medical research, certain types of “microRNAs*” and fluctuating amounts of them in the blood are found in early-stage cancers and other types of cancer. In addition to the conventional test that measures specific microRNAs in the blood, this test determines the risk of early-stage cancer by analyzing the sequence information of all small RNAs (more than 10,000 types) present in the blood through next-generation sequencing.

The National Cancer Center has high expectations for this as a new diagnostic marker because it correlates with pathological changes such as changes in sensitivity to anticancer drugs and disappearance of “cancer”.

Types of diseases that can be detected by testing

Cancer: 11 types in males

  1. brain tumor
  2. cancer of the tongue
  3. liver
  4. lung
  5. milk
  6. gullet
  7. pancreas
  8. kidney
  9. large bowel
  10. gall bladder
  11. prostate gland

Cancer: 12 types for women

  1. brain tumor
  2. cancer of the tongue
  3. liver
  4. lung
  5. milk
  6. gullet
  7. pancreas
  8. kidney
  9. large bowel
  10. gall bladder
  11. ovary
  12. cancer of the uterine body

*MicroRNAs are small RNAs (ribonucleic acid) that cannot make proteins, and cutting-edge medical technology has revealed that they are involved in the functional regulation of more than 100 genes that are involved in protein production. It is known that when the amount of microRNA is abnormal, the regulation of more than 100 genes involved also becomes abnormal, and this is linked to the development of “cancer” and various other diseases, and measuring the amount of microRNA can be used for early prediction of “cancer” diseases.

MicroRNA cancer gene test (very early detection), Alzheimer’s disease and stroke test

This test detects microRNAs in exosomes* that are produced by cancerous cells. It measures the increase or decrease in that microRNA to determine the risk of early-stage cancer. It is characterized by its ability to detect cancer at an earlier stage than conventional imaging tests or tumor markers.

Cancer Cells and MicroRNAs

Detects microRNAs secreted by diseased cells

Measurement of all small RNAs (more than 10,000 types) in blood

Enables highly accurate disease risk determination and measurement of multiple diseases in a single test

Blood microRNA levels and cancer stage and size

Detection at an earlier stage than imaging tests or existing tumor markers

  • Exosomes are granule-like substances with a diameter of 50-150 nm secreted by cells. The surface contains lipids and proteins derived from the cell membrane, while the interior contains nucleic acids (microRNA, messenger RNA, DNA, etc.), proteins, and other intracellular substances.

Inspection Flow

It takes about one month from the date of blood collection to the diagnosis by the test result report.

counseling

The director will explain the details of the examination and ask you to fill out a medical questionnaire.

drawing blood

Blood will be drawn. Only this blood is needed for the test.

examination

Genetic testing for cancer and various new diseases in the blood over a period of approximately one month.

diagnosis

The director will explain the results of the diagnosis based on the test result report. The director will provide guidance and advice on treatment methods for cancer and various disease prevention that are suited to each patient according to the results.

Charge

(data) itemFee (JPY, excl. VAT)
Cancer Gene Test (VIP)1,000,000
  • All of the above fees are only applicable to patients who can present a valid Japanese health insurance card and who are fluent in Japanese and have no difficulty with the counseling process. For other patients, please refer to the estimate after the counseling.